DJIA 16,884.05 -158.85 -0.93%
NASDAQ 4,451.64 -41.76 -0.93%
S&P 500 1,959.63 -12.66 -0.64%
market minute promo

MannKind Corp (NASDAQ: MNKD)

5.64 -0.27 (-4.57%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MNKD $5.64 -4.57%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.90
Previous Close $5.91
Daily Range $5.62 - $5.91
52-Week Range $3.80 - $11.48
Market Cap $2.3B
P/E Ratio -8.95
Dividend (Yield) $0.00 (0.0%)
Volume 3,164,751
Average Daily Volume 5,285,401
Current FY EPS -$0.33

Sector

Healthcare

Industry

Drugs

MannKind Corp (MNKD) Description

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer. Website: http://www.mannkindcorp.com/

News & Commentary Rss Feed

Bull vs. Bear: MannKind Corporation Stock

MannKind is a stock with tremendous promise -- and tremendous peril.

With Ebola Looming, When Will The Defense Department Get Around To Generex?

MannKind and Sanofi Complete Afrezza Collaboration Deal - Analyst Blog

Sanofi Vs. MannKind - Afrezza Is Better For Sanofi

MannKind Corp Becomes Oversold

Sector Update: Health Care Stocks Sinking; Mannkind Maintaining Small Rise After Finalizing Collabor

Sector Update: Health Care Stocks Sinking; Mannkind Maintaining Small Rise After Finalizing Collaboration Pact with Sanofi

Sector Update: Health Care

NASDAQ Dips 1.5%; HB Fuller Shares Decline On Downbeat Results

Markets Tumble; Scholastic Posts Wider Fiscal-First Quarter Loss

Why You Shouldn't Bet Against MannKind (MNKD) Stock - Tale of the Tape

See More MNKD News...

MNKD's Top Competitors

MNKD $5.64 (-4.57%)
Current stock: MNKD
AMGN $139.79 (-0.48%)
Current stock: AMGN
GILD $106.37 (-0.08%)
Current stock: GILD
BIIB $324.64 (-1.87%)
Current stock: BIIB